Why are MSCs therapeutic? New data: new insight

Authors

  • AI Caplan

    Corresponding author
    1. Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH 44106, USA
    • Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH 44106, USA.
    Search for more papers by this author

  • Conflict of interest statement: my colleagues and I started Osiris Therapeutics Inc. in late 1992. I no longer own stock in Osiris, neither do I have direct contact with the company.

Abstract

Adult marrow-derived mesenchymal stem cells (MSCs) are able to differentiate into bone, cartilage, muscle, marrow stroma, tendon–ligament, fat and other connective tissues. The questions can be asked, what do MSCs do naturally and where is the MSC niche? New insight and clinical experience suggest that MSCs are naturally found as perivascular cells, summarily referred to as pericytes, which are released at sites of injury, where they secrete large quantities of bioactive factors that are both immunomodulatory and trophic. The trophic activity inhibits ischaemia-caused apoptosis and scarring while stimulating angiogenesis and the mitosis of tissue intrinsic progenitor cells. The immunomodulation inhibits lymphocyte surveillance of the injured tissue, thus preventing autoimmunity, and allows allogeneic MSCs to be used in a variety of clinical situations. Thus, a new, enlightened era of experimentation and clinical trials has been initiated with xenogenic and allogeneic MSCs. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Ancillary